title: Value of cerebrospinal fluid cytochemical examination for the diagnosis of congenital toxoplasmosis at birth in France.
abstract: BACKGROUND
  Because of routine screening and treatment of pregnant women for Toxoplasma infection in France, most neonates born to mothers who seroconverted during pregnancy are either not infected or asymptomatic. Early diagnosis relies mainly on radiologic, ophthalmologic and biologic tests. Cerebrospinal fluid (CSF) cytochemical evaluation is one of several tests performed in parallel to increase the overall sensitivity of the diagnostic evaluation. Our goal was to assess the value of cytochemical examination and to confirm whether using a portion of available CSF for this analysis is legitimate.
  
  
  METHODS
  The individual performance of each of the two cytochemical tests and their combined value when used in parallel were assessed. These findings were then compared with the anti-Toxoplasma IgM and IgA serum titers and the clinical, ophthalmologic and radiologic findings at birth.
  
  
  RESULTS
  CSF cytochemical analysis was possible in only 52% of the 233 children in the study. Our results in 112 children indicated poor sensitivity estimates. There was no significant change in the posttest probability of infection compared with the pretest estimation of risk in cases of a negative finding. After a mean follow-up of 80 months there was no evidence that CSF cytochemistry helped predict the risk of sequelae.
  
  
  CONCLUSIONS
  In our setting cytochemical examination did not significantly contribute to the diagnosis of congenital infection at birth. Because of the limited quantity of CSF available, we suggest the use of other methods with higher yield.
authors.affiliation: Parasitology Department, Hôpital de la Croix-Rousse, Lyon, France. wallon@rockefeller.univ-lyon1.fr
authors.forename: M
authors.initials: M
authors.lastname: Wallon
authors.forename: C
authors.initials: C
authors.lastname: Caudie
authors.forename: S
authors.initials: S
authors.lastname: Rubio
authors.forename: L
authors.initials: L
authors.lastname: Bellini
authors.forename: V
authors.initials: V
authors.lastname: Girault
authors.forename: F
authors.initials: F
authors.lastname: Gay-Andrieu
authors.forename: F
authors.initials: F
authors.lastname: Peyron
mesh_terms: D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D002555:Cerebrospinal Fluid / Q000469:parasitology*; D004797:Enzyme-Linked Immunosorbent Assay; D005069:Evaluation Studies as Topic; D005260:Female; D005602:France; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007231:Infant, Newborn; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000517:prevention & control; D011264:Pregnancy Trimesters; D014122:Toxoplasma / Q000302:isolation & purification; D014125:Toxoplasmosis, Congenital / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000517:prevention & control
chemical_list: D000913:Antibodies, Protozoan; D007074:Immunoglobulin G; D007075:Immunoglobulin M